Following invitation by IFPMA and EFPIA, WHO/Europe Regional Director introduces Oslo Medicines Initiative to Biopharmaceutical CEO Roundtable

22-06-2021

Following an invitation by the International Federation of Pharmaceutical Associations (IFPMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), WHO Regional Director for Europe Dr Hans Henri P. Kluge met with members of the Biopharmaceutical CEO Roundtable.

During the meeting, they discussed the Oslo Medicines Initiative (OMI) and how industry could contribute to the initiative’s vision for collaboration between public and private sectors to improve sustainable access to effective, high-cost novel medicines across the WHO European Region.